Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for April, 2009

Is liraglutide in trouble?

Friday, April 3rd, 2009

Well, judging from this week’s unexpected twist, the fate of the Novo Nordisk diabetes candidate, heralded for its rare feat of controlling blood sugar while also reducing weight, is suddenly less certain. The company’s European shares are slumping after an FDA panel split on endorsing liraglutide amid evidence that the ...

Crisis a mixed bag for CROs

Wednesday, April 1st, 2009

Pharma’s blueprint for surviving the economic hailstorm has been pretty easy to follow (see mergers, see more mergers, see R&D cutbacks, etc.). Ditto for the struggling biotech sector, where funding woes have been well documented. But what about the contract research sector, you may be wondering? How exactly has the financial ...

   
©2012 UBM Canon